Chlorogenic Acid

Chlorogenic Acid

SCHEMBL1230489

O=C(C=Cc1ccc(O)c(O)c1)OC1CC(O)(C(=O)O)CC(O)C1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 6/20 1.00
PTPN1 P18031 6/20 1.00
APP P05067 5/20 1.00
HSD17B10 Q99714 4/20 1.00
AKR1B10 O60218 4/20 1.00
KDM4E B2RXH2 3/20 1.00
ALDH1A1 P00352 2/20 1.00
TSHR P16473 1/20 1.00
TDP1 Q9NUW8 1/20 1.00
HDAC3 O15379 1/20 1.00
PTPN2 P17706 1/20 1.00
HDAC4 P56524 1/20 1.00
HDAC1 Q13547 1/20 1.00
HDAC7 Q8WUI4 1/20 1.00
HDAC2 Q92769 1/20 1.00
HDAC10 Q969S8 1/20 1.00
HDAC11 Q96DB2 1/20 1.00
HDAC8 Q9BY41 1/20 1.00
HDAC6 Q9UBN7 1/20 1.00
HDAC9 Q9UKV0 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chlorogenic Acid SCHEMBL1228850 1.00 AKR1B1 (1.00) AKR1B1PTPN1APPHSD17B10AKR1B10
Chlorogenic Acid SCHEMBL22111591 1.00 AKR1B1 (1.00) AKR1B1PTPN1APPHSD17B10AKR1B10
Chlorogenic Acid SCHEMBL15590670 1.00 AKR1B1 (1.00) AKR1B1PTPN1APPHSD17B10AKR1B10
Chlorogenic Acid SCHEMBL24239743 1.00 AKR1B1 (1.00) AKR1B1PTPN1APPHSD17B10AKR1B10
Chlorogenic Acid SCHEMBL21191546 1.00 AKR1B1 (1.00) AKR1B1PTPN1APPHSD17B10AKR1B10
Chlorogenic Acid SCHEMBL24879283 1.00 AKR1B1 (1.00) AKR1B1PTPN1APPHSD17B10AKR1B10
Chlorogenic Acid SCHEMBL21433650 1.00 AKR1B1 (1.00) AKR1B1PTPN1APPHSD17B10AKR1B10
Chlorogenic Acid SCHEMBL22422499 1.00 AKR1B1 (1.00) AKR1B1PTPN1APPHSD17B10AKR1B10
Chlorogenic Acid SCHEMBL21142437 1.00 AKR1B1 (1.00) AKR1B1PTPN1APPHSD17B10AKR1B10
Chlorogenic Acid SCHEMBL10182527 1.00 AKR1B1 (1.00) AKR1B1PTPN1APPHSD17B10AKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169166-A1 CYCLOHEXANECARBOXYLIC ACIDS FOR SELECTIVE TASTE MASKING International Flavors & Fragrances Inc. (US) 2017-05-24 EP claimed
WO-2016209664-A1 CYCLOHEXANECARBOXYLIC ACIDS FOR SELECTIVE TASTE MASKING INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2016-12-29 WO claimed
US-7881871-B2 Method for designing surfaces BIO-LAYER PTY LIMITED (AU) 2011-02-01 US claimed
EP-1700244-A4 A METHOD FOR DESIGNING SURFACES BIO LAYER PTY LTD (AU) 2009-07-08 EP claimed
US-20070099235-A1 Method for designing surfaces BIO-LAYER PTY LIMITED (AU) 2007-05-03 US claimed
EP-1700244-A1 A METHOD FOR DESIGNING SURFACES Bio-Layer Pty Limited (AU) 2006-09-13 EP claimed
WO-2005057462-A1 A METHOD FOR DESIGNING SURFACES BIO-LAYER PTY LIMITED (AU) 2005-06-23 WO claimed
US-20250340675-A1 NEW HYALURONIC ACID DERIVATIVES AS INNOVATIVE FILLERS WiQo S.P.A. (IT) 2025-11-06 US disclosed
EP-4448588-A1 NEW HYALURONIC ACID DERIVATIVES AS INNOVATIVE FILLERS WiQo S.p.A. (IT) 2024-10-23 EP disclosed
CN-118742576-A Novel hyaluronic acid derivatives as innovative fillers 维库有限公司 2024-10-01 CN disclosed
CN-118045124-A Medicinal and edible composition and preparation method and application thereof 福建农林大学 2024-05-17 CN disclosed
WO-2023135135-A1 NEW HYALURONIC ACID DERIVATIVES AS INNOVATIVE FILLERS GPQ S.R.L. (IT) 2023-07-20 WO disclosed
US-11219230-B2 Mixtures with stabilising properties SYMRISE AG (DE) 2022-01-11 US disclosed
WO-2001066106-A1 A PHARMACEUTICAL COMPOSITION HAVING CHLOROGENIC ACID AS ACTIVE COMPONENT FOR PREVENTING OR TREATING THE DECLINING OF MALE REPRODUCTION CAPABILITY WOORICHEM TECH CO., LTD. (KR) 2001-09-13 WO disclosed
EP-1094724-A1 USE OF A PHENOL OXIDISING ENZYME IN THE TREATMENT OF TOBACCO Novozymes A/S (DK) 2001-05-02 EP disclosed
EP-1007068-A4 PROCESS FOR PREPARING SYNTHETIC SOIL-EXTRACT MATERIALS AND MEDICAMENTS BASED THEREON LAUB BIOCHEMICALS CORP (US) 2001-04-25 EP disclosed
EP-1007068-A1 PROCESS FOR PREPARING SYNTHETIC SOIL-EXTRACT MATERIALS AND MEDICAMENTS BASED THEREON Laub Biochemicals Corporation (US) 2000-06-14 EP disclosed
WO-2000002464-A1 USE OF A PHENOL OXIDISING ENZYME IN THE TREATMENT OF TOBACCO NOVOZYMES A/S (DK) 2000-01-20 WO disclosed
US-5945446-A Process for preparing synthetic soil-extract materials and medicaments based thereon LAUBC BIOCHEMICALS, CORPORATION (US) 1999-08-31 US disclosed
WO-1998034629-A1 PROCESS FOR PREPARING SYNTHETIC SOIL-EXTRACT MATERIALS AND MEDICAMENTS BASED THEREON LAUB BIOCHEMICALS CORPORATION (US) 1998-08-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11219230-B2 Mixtures with stabilising properties LPO, TAS2R50, TAS2R10 AKR1B1 945/4885PTPN1 2225/4885APP 2515/4885
US-20250340675-A1 NEW HYALURONIC ACID DERIVATIVES AS INNOVATIVE FILLERS CD44, MMP1, HAAO AKR1B1 3346/4885PTPN1 4618/4885APP 4602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.